0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Gene Therapy Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-17O13612
Home | Market Reports | Health| Pharmacy
Global Human Gene Therapy Market Research Report 2023
BUY CHAPTERS

Global Human Gene Therapy Market Research Report 2025

Code: QYRE-Auto-17O13612
Report
February 2025
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Gene Therapy Market Size

The global market for Human Gene Therapy was valued at US$ 5677 million in the year 2024 and is projected to reach a revised size of US$ 8655 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Human Gene Therapy Market

Human Gene Therapy Market

Gene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person"s genetic makeup instead of using drugs or surgery.
Advances in gene therapy technology, increasing understanding of genetics, and the potential for addressing previously untreatable diseases contribute to the growth of the Human Gene Therapy market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Gene Therapy.
The Human Gene Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Gene Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Gene Therapy Market Report

Report Metric Details
Report Name Human Gene Therapy Market
Accounted market size in year US$ 5677 million
Forecasted market size in 2031 US$ 8655 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics, Anges, Bluebird Bio, Jazz Pharmaceuticals, Dynavax Technologies, Human Stem Cells Institute, Sibiono Genetech, Shanghai Sunway Biotech, Uniqure N.V., Gensight Biologics S.A., Celgene Corporation, Cellectis, Sangamo Therapeutics, Mustang Bio, AGTC, Poseida Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Gene Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Gene Therapy Market growing?

Ans: The Human Gene Therapy Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Human Gene Therapy Market size in 2031?

Ans: The Human Gene Therapy Market size in 2031 will be US$ 8655 million.

Who are the main players in the Human Gene Therapy Market report?

Ans: The main players in the Human Gene Therapy Market are Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics, Anges, Bluebird Bio, Jazz Pharmaceuticals, Dynavax Technologies, Human Stem Cells Institute, Sibiono Genetech, Shanghai Sunway Biotech, Uniqure N.V., Gensight Biologics S.A., Celgene Corporation, Cellectis, Sangamo Therapeutics, Mustang Bio, AGTC, Poseida Therapeutics

What are the Application segmentation covered in the Human Gene Therapy Market report?

Ans: The Applications covered in the Human Gene Therapy Market report are Neurological Diseases, Cancer, DMD (Duchenne Muscular Dystrophy), Hepatological Diseases, Others

What are the Type segmentation covered in the Human Gene Therapy Market report?

Ans: The Types covered in the Human Gene Therapy Market report are Non-viral Vectors, Viral Vectors

Recommended Reports

Gene Therapy Core

Gene Therapy Manufacturing

Gene Therapy Delivery

1 Human Gene Therapy Market Overview
1.1 Product Definition
1.2 Human Gene Therapy by Type
1.2.1 Global Human Gene Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Non-viral Vectors
1.2.3 Viral Vectors
1.3 Human Gene Therapy by Application
1.3.1 Global Human Gene Therapy Market Value by Application (2024 VS 2031)
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 DMD (Duchenne Muscular Dystrophy)
1.3.5 Hepatological Diseases
1.3.6 Others
1.4 Global Human Gene Therapy Market Size Estimates and Forecasts
1.4.1 Global Human Gene Therapy Revenue 2020-2031
1.4.2 Global Human Gene Therapy Sales 2020-2031
1.4.3 Global Human Gene Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Gene Therapy Market Competition by Manufacturers
2.1 Global Human Gene Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Gene Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Gene Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Gene Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Gene Therapy, Product Type & Application
2.7 Global Key Manufacturers of Human Gene Therapy, Date of Enter into This Industry
2.8 Global Human Gene Therapy Market Competitive Situation and Trends
2.8.1 Global Human Gene Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue
2.8.3 Global Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Gene Therapy Market Scenario by Region
3.1 Global Human Gene Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Gene Therapy Sales by Region: 2020-2031
3.2.1 Global Human Gene Therapy Sales by Region: 2020-2025
3.2.2 Global Human Gene Therapy Sales by Region: 2026-2031
3.3 Global Human Gene Therapy Revenue by Region: 2020-2031
3.3.1 Global Human Gene Therapy Revenue by Region: 2020-2025
3.3.2 Global Human Gene Therapy Revenue by Region: 2026-2031
3.4 North America Human Gene Therapy Market Facts & Figures by Country
3.4.1 North America Human Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Gene Therapy Sales by Country (2020-2031)
3.4.3 North America Human Gene Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Gene Therapy Market Facts & Figures by Country
3.5.1 Europe Human Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Gene Therapy Sales by Country (2020-2031)
3.5.3 Europe Human Gene Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Gene Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Human Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Gene Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Gene Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Gene Therapy Market Facts & Figures by Country
3.7.1 Latin America Human Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Gene Therapy Sales by Country (2020-2031)
3.7.3 Latin America Human Gene Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Gene Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Gene Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Gene Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Gene Therapy Sales by Type (2020-2031)
4.1.1 Global Human Gene Therapy Sales by Type (2020-2025)
4.1.2 Global Human Gene Therapy Sales by Type (2026-2031)
4.1.3 Global Human Gene Therapy Sales Market Share by Type (2020-2031)
4.2 Global Human Gene Therapy Revenue by Type (2020-2031)
4.2.1 Global Human Gene Therapy Revenue by Type (2020-2025)
4.2.2 Global Human Gene Therapy Revenue by Type (2026-2031)
4.2.3 Global Human Gene Therapy Revenue Market Share by Type (2020-2031)
4.3 Global Human Gene Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Gene Therapy Sales by Application (2020-2031)
5.1.1 Global Human Gene Therapy Sales by Application (2020-2025)
5.1.2 Global Human Gene Therapy Sales by Application (2026-2031)
5.1.3 Global Human Gene Therapy Sales Market Share by Application (2020-2031)
5.2 Global Human Gene Therapy Revenue by Application (2020-2031)
5.2.1 Global Human Gene Therapy Revenue by Application (2020-2025)
5.2.2 Global Human Gene Therapy Revenue by Application (2026-2031)
5.2.3 Global Human Gene Therapy Revenue Market Share by Application (2020-2031)
5.3 Global Human Gene Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biogen
6.1.1 Biogen Company Information
6.1.2 Biogen Description and Business Overview
6.1.3 Biogen Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biogen Human Gene Therapy Product Portfolio
6.1.5 Biogen Recent Developments/Updates
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Company Information
6.2.2 Sarepta Therapeutics Description and Business Overview
6.2.3 Sarepta Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sarepta Therapeutics Human Gene Therapy Product Portfolio
6.2.5 Sarepta Therapeutics Recent Developments/Updates
6.3 Gilead Sciences
6.3.1 Gilead Sciences Company Information
6.3.2 Gilead Sciences Description and Business Overview
6.3.3 Gilead Sciences Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gilead Sciences Human Gene Therapy Product Portfolio
6.3.5 Gilead Sciences Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Company Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amgen Human Gene Therapy Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Human Gene Therapy Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Orchard Therapeutics
6.6.1 Orchard Therapeutics Company Information
6.6.2 Orchard Therapeutics Description and Business Overview
6.6.3 Orchard Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Orchard Therapeutics Human Gene Therapy Product Portfolio
6.6.5 Orchard Therapeutics Recent Developments/Updates
6.7 Spark Therapeutics
6.7.1 Spark Therapeutics Company Information
6.7.2 Spark Therapeutics Description and Business Overview
6.7.3 Spark Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Spark Therapeutics Human Gene Therapy Product Portfolio
6.7.5 Spark Therapeutics Recent Developments/Updates
6.8 Agc Biologics
6.8.1 Agc Biologics Company Information
6.8.2 Agc Biologics Description and Business Overview
6.8.3 Agc Biologics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Agc Biologics Human Gene Therapy Product Portfolio
6.8.5 Agc Biologics Recent Developments/Updates
6.9 Anges
6.9.1 Anges Company Information
6.9.2 Anges Description and Business Overview
6.9.3 Anges Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Anges Human Gene Therapy Product Portfolio
6.9.5 Anges Recent Developments/Updates
6.10 Bluebird Bio
6.10.1 Bluebird Bio Company Information
6.10.2 Bluebird Bio Description and Business Overview
6.10.3 Bluebird Bio Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bluebird Bio Human Gene Therapy Product Portfolio
6.10.5 Bluebird Bio Recent Developments/Updates
6.11 Jazz Pharmaceuticals
6.11.1 Jazz Pharmaceuticals Company Information
6.11.2 Jazz Pharmaceuticals Description and Business Overview
6.11.3 Jazz Pharmaceuticals Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jazz Pharmaceuticals Human Gene Therapy Product Portfolio
6.11.5 Jazz Pharmaceuticals Recent Developments/Updates
6.12 Dynavax Technologies
6.12.1 Dynavax Technologies Company Information
6.12.2 Dynavax Technologies Description and Business Overview
6.12.3 Dynavax Technologies Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dynavax Technologies Human Gene Therapy Product Portfolio
6.12.5 Dynavax Technologies Recent Developments/Updates
6.13 Human Stem Cells Institute
6.13.1 Human Stem Cells Institute Company Information
6.13.2 Human Stem Cells Institute Description and Business Overview
6.13.3 Human Stem Cells Institute Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Human Stem Cells Institute Human Gene Therapy Product Portfolio
6.13.5 Human Stem Cells Institute Recent Developments/Updates
6.14 Sibiono Genetech
6.14.1 Sibiono Genetech Company Information
6.14.2 Sibiono Genetech Description and Business Overview
6.14.3 Sibiono Genetech Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sibiono Genetech Human Gene Therapy Product Portfolio
6.14.5 Sibiono Genetech Recent Developments/Updates
6.15 Shanghai Sunway Biotech
6.15.1 Shanghai Sunway Biotech Company Information
6.15.2 Shanghai Sunway Biotech Description and Business Overview
6.15.3 Shanghai Sunway Biotech Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shanghai Sunway Biotech Human Gene Therapy Product Portfolio
6.15.5 Shanghai Sunway Biotech Recent Developments/Updates
6.16 Uniqure N.V.
6.16.1 Uniqure N.V. Company Information
6.16.2 Uniqure N.V. Description and Business Overview
6.16.3 Uniqure N.V. Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Uniqure N.V. Human Gene Therapy Product Portfolio
6.16.5 Uniqure N.V. Recent Developments/Updates
6.17 Gensight Biologics S.A.
6.17.1 Gensight Biologics S.A. Company Information
6.17.2 Gensight Biologics S.A. Description and Business Overview
6.17.3 Gensight Biologics S.A. Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Gensight Biologics S.A. Human Gene Therapy Product Portfolio
6.17.5 Gensight Biologics S.A. Recent Developments/Updates
6.18 Celgene Corporation
6.18.1 Celgene Corporation Company Information
6.18.2 Celgene Corporation Description and Business Overview
6.18.3 Celgene Corporation Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Celgene Corporation Human Gene Therapy Product Portfolio
6.18.5 Celgene Corporation Recent Developments/Updates
6.19 Cellectis
6.19.1 Cellectis Company Information
6.19.2 Cellectis Description and Business Overview
6.19.3 Cellectis Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Cellectis Human Gene Therapy Product Portfolio
6.19.5 Cellectis Recent Developments/Updates
6.20 Sangamo Therapeutics
6.20.1 Sangamo Therapeutics Company Information
6.20.2 Sangamo Therapeutics Description and Business Overview
6.20.3 Sangamo Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Sangamo Therapeutics Human Gene Therapy Product Portfolio
6.20.5 Sangamo Therapeutics Recent Developments/Updates
6.21 Mustang Bio
6.21.1 Mustang Bio Company Information
6.21.2 Mustang Bio Description and Business Overview
6.21.3 Mustang Bio Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Mustang Bio Human Gene Therapy Product Portfolio
6.21.5 Mustang Bio Recent Developments/Updates
6.22 AGTC
6.22.1 AGTC Company Information
6.22.2 AGTC Description and Business Overview
6.22.3 AGTC Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.22.4 AGTC Human Gene Therapy Product Portfolio
6.22.5 AGTC Recent Developments/Updates
6.23 Poseida Therapeutics
6.23.1 Poseida Therapeutics Company Information
6.23.2 Poseida Therapeutics Description and Business Overview
6.23.3 Poseida Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Poseida Therapeutics Human Gene Therapy Product Portfolio
6.23.5 Poseida Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Gene Therapy Industry Chain Analysis
7.2 Human Gene Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Gene Therapy Production Mode & Process Analysis
7.4 Human Gene Therapy Sales and Marketing
7.4.1 Human Gene Therapy Sales Channels
7.4.2 Human Gene Therapy Distributors
7.5 Human Gene Therapy Customer Analysis
8 Human Gene Therapy Market Dynamics
8.1 Human Gene Therapy Industry Trends
8.2 Human Gene Therapy Market Drivers
8.3 Human Gene Therapy Market Challenges
8.4 Human Gene Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Gene Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Gene Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Gene Therapy Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Gene Therapy Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Human Gene Therapy Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Gene Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Gene Therapy Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Gene Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Gene Therapy, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Gene Therapy, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Gene Therapy, Product Type & Application
 Table 12. Global Key Manufacturers of Human Gene Therapy, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Gene Therapy Sales by Region (2020-2025) & (K Units)
 Table 18. Global Human Gene Therapy Sales Market Share by Region (2020-2025)
 Table 19. Global Human Gene Therapy Sales by Region (2026-2031) & (K Units)
 Table 20. Global Human Gene Therapy Sales Market Share by Region (2026-2031)
 Table 21. Global Human Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Gene Therapy Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Gene Therapy Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Gene Therapy Sales by Country (2020-2025) & (K Units)
 Table 27. North America Human Gene Therapy Sales by Country (2026-2031) & (K Units)
 Table 28. North America Human Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Gene Therapy Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Human Gene Therapy Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Human Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Gene Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Gene Therapy Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Human Gene Therapy Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Human Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Gene Therapy Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Human Gene Therapy Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Human Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Gene Therapy Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Human Gene Therapy Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Human Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Gene Therapy Sales (K Units) by Type (2020-2025)
 Table 51. Global Human Gene Therapy Sales (K Units) by Type (2026-2031)
 Table 52. Global Human Gene Therapy Sales Market Share by Type (2020-2025)
 Table 53. Global Human Gene Therapy Sales Market Share by Type (2026-2031)
 Table 54. Global Human Gene Therapy Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Gene Therapy Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Gene Therapy Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Gene Therapy Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Gene Therapy Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Human Gene Therapy Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Human Gene Therapy Sales (K Units) by Application (2020-2025)
 Table 61. Global Human Gene Therapy Sales (K Units) by Application (2026-2031)
 Table 62. Global Human Gene Therapy Sales Market Share by Application (2020-2025)
 Table 63. Global Human Gene Therapy Sales Market Share by Application (2026-2031)
 Table 64. Global Human Gene Therapy Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Gene Therapy Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Gene Therapy Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Gene Therapy Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Gene Therapy Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Human Gene Therapy Price (US$/Unit) by Application (2026-2031)
 Table 70. Biogen Company Information
 Table 71. Biogen Description and Business Overview
 Table 72. Biogen Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Biogen Human Gene Therapy Product
 Table 74. Biogen Recent Developments/Updates
 Table 75. Sarepta Therapeutics Company Information
 Table 76. Sarepta Therapeutics Description and Business Overview
 Table 77. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sarepta Therapeutics Human Gene Therapy Product
 Table 79. Sarepta Therapeutics Recent Developments/Updates
 Table 80. Gilead Sciences Company Information
 Table 81. Gilead Sciences Description and Business Overview
 Table 82. Gilead Sciences Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Gilead Sciences Human Gene Therapy Product
 Table 84. Gilead Sciences Recent Developments/Updates
 Table 85. Amgen Company Information
 Table 86. Amgen Description and Business Overview
 Table 87. Amgen Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Amgen Human Gene Therapy Product
 Table 89. Amgen Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis Human Gene Therapy Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Orchard Therapeutics Company Information
 Table 96. Orchard Therapeutics Description and Business Overview
 Table 97. Orchard Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Orchard Therapeutics Human Gene Therapy Product
 Table 99. Orchard Therapeutics Recent Developments/Updates
 Table 100. Spark Therapeutics Company Information
 Table 101. Spark Therapeutics Description and Business Overview
 Table 102. Spark Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Spark Therapeutics Human Gene Therapy Product
 Table 104. Spark Therapeutics Recent Developments/Updates
 Table 105. Agc Biologics Company Information
 Table 106. Agc Biologics Description and Business Overview
 Table 107. Agc Biologics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Agc Biologics Human Gene Therapy Product
 Table 109. Agc Biologics Recent Developments/Updates
 Table 110. Anges Company Information
 Table 111. Anges Description and Business Overview
 Table 112. Anges Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Anges Human Gene Therapy Product
 Table 114. Anges Recent Developments/Updates
 Table 115. Bluebird Bio Company Information
 Table 116. Bluebird Bio Description and Business Overview
 Table 117. Bluebird Bio Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Bluebird Bio Human Gene Therapy Product
 Table 119. Bluebird Bio Recent Developments/Updates
 Table 120. Jazz Pharmaceuticals Company Information
 Table 121. Jazz Pharmaceuticals Description and Business Overview
 Table 122. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Jazz Pharmaceuticals Human Gene Therapy Product
 Table 124. Jazz Pharmaceuticals Recent Developments/Updates
 Table 125. Dynavax Technologies Company Information
 Table 126. Dynavax Technologies Description and Business Overview
 Table 127. Dynavax Technologies Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Dynavax Technologies Human Gene Therapy Product
 Table 129. Dynavax Technologies Recent Developments/Updates
 Table 130. Human Stem Cells Institute Company Information
 Table 131. Human Stem Cells Institute Description and Business Overview
 Table 132. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Human Stem Cells Institute Human Gene Therapy Product
 Table 134. Human Stem Cells Institute Recent Developments/Updates
 Table 135. Sibiono Genetech Company Information
 Table 136. Sibiono Genetech Description and Business Overview
 Table 137. Sibiono Genetech Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sibiono Genetech Human Gene Therapy Product
 Table 139. Sibiono Genetech Recent Developments/Updates
 Table 140. Shanghai Sunway Biotech Company Information
 Table 141. Shanghai Sunway Biotech Description and Business Overview
 Table 142. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Shanghai Sunway Biotech Human Gene Therapy Product
 Table 144. Shanghai Sunway Biotech Recent Developments/Updates
 Table 145. Uniqure N.V. Company Information
 Table 146. Uniqure N.V. Description and Business Overview
 Table 147. Uniqure N.V. Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Uniqure N.V. Human Gene Therapy Product
 Table 149. Uniqure N.V. Recent Developments/Updates
 Table 150. Gensight Biologics S.A. Company Information
 Table 151. Gensight Biologics S.A. Description and Business Overview
 Table 152. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Gensight Biologics S.A. Human Gene Therapy Product
 Table 154. Gensight Biologics S.A. Recent Developments/Updates
 Table 155. Celgene Corporation Company Information
 Table 156. Celgene Corporation Description and Business Overview
 Table 157. Celgene Corporation Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Celgene Corporation Human Gene Therapy Product
 Table 159. Celgene Corporation Recent Developments/Updates
 Table 160. Cellectis Company Information
 Table 161. Cellectis Description and Business Overview
 Table 162. Cellectis Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Cellectis Human Gene Therapy Product
 Table 164. Cellectis Recent Developments/Updates
 Table 165. Sangamo Therapeutics Company Information
 Table 166. Sangamo Therapeutics Description and Business Overview
 Table 167. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Sangamo Therapeutics Human Gene Therapy Product
 Table 169. Sangamo Therapeutics Recent Developments/Updates
 Table 170. Mustang Bio Company Information
 Table 171. Mustang Bio Description and Business Overview
 Table 172. Mustang Bio Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Mustang Bio Human Gene Therapy Product
 Table 174. Mustang Bio Recent Developments/Updates
 Table 175. AGTC Company Information
 Table 176. AGTC Description and Business Overview
 Table 177. AGTC Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. AGTC Human Gene Therapy Product
 Table 179. AGTC Recent Developments/Updates
 Table 180. Poseida Therapeutics Company Information
 Table 181. Poseida Therapeutics Description and Business Overview
 Table 182. Poseida Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Poseida Therapeutics Human Gene Therapy Product
 Table 184. Poseida Therapeutics Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. Human Gene Therapy Distributors List
 Table 188. Human Gene Therapy Customers List
 Table 189. Human Gene Therapy Market Trends
 Table 190. Human Gene Therapy Market Drivers
 Table 191. Human Gene Therapy Market Challenges
 Table 192. Human Gene Therapy Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Gene Therapy
 Figure 2. Global Human Gene Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Gene Therapy Market Share by Type: 2024 & 2031
 Figure 4. Non-viral Vectors Product Picture
 Figure 5. Viral Vectors Product Picture
 Figure 6. Global Human Gene Therapy Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Gene Therapy Market Share by Application: 2024 & 2031
 Figure 8. Neurological Diseases
 Figure 9. Cancer
 Figure 10. DMD (Duchenne Muscular Dystrophy)
 Figure 11. Hepatological Diseases
 Figure 12. Others
 Figure 13. Global Human Gene Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Human Gene Therapy Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Human Gene Therapy Sales (2020-2031) & (K Units)
 Figure 16. Global Human Gene Therapy Average Price (US$/Unit) & (2020-2031)
 Figure 17. Human Gene Therapy Report Years Considered
 Figure 18. Human Gene Therapy Sales Share by Manufacturers in 2024
 Figure 19. Global Human Gene Therapy Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Human Gene Therapy Players: Market Share by Revenue in Human Gene Therapy in 2024
 Figure 21. Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Human Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Human Gene Therapy Sales Market Share by Country (2020-2031)
 Figure 24. North America Human Gene Therapy Revenue Market Share by Country (2020-2031)
 Figure 25. United States Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Human Gene Therapy Sales Market Share by Country (2020-2031)
 Figure 28. Europe Human Gene Therapy Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Human Gene Therapy Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Human Gene Therapy Revenue Market Share by Region (2020-2031)
 Figure 36. China Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Human Gene Therapy Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Human Gene Therapy Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Human Gene Therapy Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Human Gene Therapy Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Human Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Human Gene Therapy by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Human Gene Therapy by Type (2020-2031)
 Figure 57. Global Human Gene Therapy Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Human Gene Therapy by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Human Gene Therapy by Application (2020-2031)
 Figure 60. Global Human Gene Therapy Price (US$/Unit) by Application (2020-2031)
 Figure 61. Human Gene Therapy Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Jet Lag Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0R20253
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart